Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Shares Outstanding (Weighted Average) (2016 - 2020)

Historic Shares Outstanding (Weighted Average) for Collegium Pharmaceutical (COLL) over the last 5 years, with Q1 2020 value amounting to $34.1 million.

  • Collegium Pharmaceutical's Shares Outstanding (Weighted Average) rose 230.64% to $34.1 million in Q1 2020 from the same period last year, while for Mar 2020 it was $34.1 million, marking a year-over-year increase of 230.64%. This contributed to the annual value of $33.6 million for FY2019, which is 196.26% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Shares Outstanding (Weighted Average) stood at $34.1 million for Q1 2020, which was up 230.64% from $33.6 million recorded in Q4 2019.
  • In the past 5 years, Collegium Pharmaceutical's Shares Outstanding (Weighted Average) ranged from a high of $34.1 million in Q1 2020 and a low of $23.1 million during Q1 2016
  • In the last 5 years, Collegium Pharmaceutical's Shares Outstanding (Weighted Average) had a median value of $32.9 million in 2018 and averaged $30.2 million.
  • As far as peak fluctuations go, Collegium Pharmaceutical's Shares Outstanding (Weighted Average) skyrocketed by 2689.18% in 2017, and later soared by 130.15% in 2019.
  • Over the past 5 years, Collegium Pharmaceutical's Shares Outstanding (Weighted Average) (Quarter) stood at $24.3 million in 2016, then increased by 24.74% to $30.3 million in 2017, then rose by 8.88% to $33.0 million in 2018, then grew by 1.96% to $33.6 million in 2019, then rose by 1.49% to $34.1 million in 2020.
  • Its Shares Outstanding (Weighted Average) was $34.1 million in Q1 2020, compared to $33.6 million in Q4 2019 and $33.5 million in Q3 2019.